-
Applied DNA reaches new milestones
biospectrumasia
August 03, 2018
In the past 12 months, Applied DNA has shipped over 8,000 milligrams of PCR-produced linear DNA for use in Diagnostic and Therapeutic applications.
-
Is the Chinese CRO Industry still the “Low-end Laboratory” of Multinational Pharmaceutical Enterprises?
Xiaoyaowan
May 31, 2018
The Chinese CRO unicorn WuXi AppTec was officially listed on Shanghai Stock Exchange on May 8
-
VEEDA CRO launches new website
financialexpress
May 21, 2018
VEEDA CRO has launched its newly revamped website, www.veedacr.com, that aims to create a user-friendly browsing experience for customers and business partners.
-
RxCelerate acquires bioanalysis CRO Total Scientific
fiercepharma
May 08, 2018
RxCelerate has absorbed the services and staff of Total Scientific, a CRO focused in bioanalysis, protein assays and gene-phenotype association.
-
Buying Excipients and APIs Could be Done Better
Emil W. Ciurczak, Doramaxx Consulting
December 25, 2017
I have spent years dealing with the transfer of methods throughout a greatly extended supply chain.
-
JSR Life Sciences Snaps Up CRO in $400M Deal
biospace
December 21, 2017
The parent company of JSR Life Sciences snapped up contract research organization Crown Bioscience International for $400 million, the company announced this morning.
-
Elligo Health Research, Allscripts team up to bring clinical research to physicians
fiercebiotech
August 24, 2017
Elligo Health Research and Allscripts have formed a strategic partnership using electronic health records to bring clinical trials to clinics.
-
Parexel, Osaka International Cancer Institute combine for Japan trial work Parexel, Osaka Internatio
fiercebiotech
August 23, 2017
Parexel has offices in Tokyo, Kobe and Osaka.
-
Olon SpA Acquires Part of Ricerca Biosciences
contractpharma
June 14, 2017
Strengthens service offering of global CDMO and generics provider for research and manufacturing
-
Chiltern Acquires Japanese CRO
contractpharma
June 01, 2017
Offers expertise in establishing regulatory and development pathways for Japan and Pan Asian clinical trials